Expression of the three myeloid cell-associated immunoglobulin G Fc receptors defined by murine monoclonal antibodies on normal bone marrow and acute leukemia cells
- PMID: 2469504
Expression of the three myeloid cell-associated immunoglobulin G Fc receptors defined by murine monoclonal antibodies on normal bone marrow and acute leukemia cells
Abstract
Monoclonal antibodies (MoAbs) have been prepared recently that recognize the three cell-surface receptors for the Fc portion of immunoglobulin (Ig), termed Fc gamma RI (MoAb 32.2), Fc gamma R II (MoAb IV-3), and Fc gamma R III (MoAb 3G8) that are expressed on selected subsets of non-T lymphocyte peripheral blood leukocytes. In the blood, Fc gamma R I is expressed exclusively on monocytes and macrophages, Fc gamma R II on granulocytes, mononuclear phagocytes, platelets, and B cells, and Fc gamma R III on granulocytes and natural killer (NK) cells. We have examined the expression of these molecules on normal bone marrow (BM) cells and on leukemia cells from the blood and/or BM in order to determine their normal ontogeny as well as their distribution on leukemic cells. BM was obtained from six normal volunteers and from 170 patients with newly diagnosed acute leukemia. Normal BM cells were found to express Fc gamma R I, II, and III with the following percentages: 40%, 58%, and 56%, respectively. Cell sorting revealed that both Fc gamma R I and Fc gamma R II were detectable on all subclasses of myeloid precursors as early as myeloblasts. Cell sorting experiments revealed that 66% of the granulocyte-monocyte colony-forming cells (CFU-GM) and 50% of erythroid burst-forming units (BFU-E) were Fc gamma R II positive with only 20% and 28%, respectively, of CFU-GM and BFU-E were Fc gamma R I positive. Acute myeloid leukemia (AML) cells expressed the three receptors with the following frequency (n = 146): Fc gamma R I, 58%; Fc gamma R II, 67%; and Fc gamma R III, 26% of patients. Despite the fact that Fc gamma R I is only expressed on monocytes among blood cells, AML cells without monocytoid differentiation (French-American-British [FAB]M1, M2, M3, M6) were sometimes positive for this receptor. However, Fc gamma R I was highly correlated with FAB M4 and M5 morphology (P less than .001). Fc gamma R II was also correlated with FAB M4 and M5 morphology (P = .003). Cells from 11 patients with acute lymphoblastic leukemia were negative for Fc gamma R I, but six cases were positive for Fc gamma R II and III (not the same patients). These studies demonstrate that Ig Fc gamma R are acquired during normal differentiation in the BM at or before the level of colony-forming units. In addition, we show that acute leukemia cells commonly express Fc gamma R.
Similar articles
-
Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.Leukemia. 1989 Jun;3(6):446-52. Leukemia. 1989. PMID: 2657231
-
Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.Exp Hematol. 1988 Mar;16(3):176-83. Exp Hematol. 1988. PMID: 3422192
-
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.Leukemia. 1997 Oct;11(10):1700-10. doi: 10.1038/sj.leu.2400794. Leukemia. 1997. PMID: 9324292
-
Fc receptors of human Langerhans cells.J Invest Dermatol. 1990 Jun;94(6 Suppl):15S-21S. doi: 10.1111/1523-1747.ep12874984. J Invest Dermatol. 1990. PMID: 2191049 Review.
-
Cell surface markers in leukemia: biological and clinical correlations.Crit Rev Oncol Hematol. 1985;2(3):209-60. doi: 10.1016/s1040-8428(85)80003-2. Crit Rev Oncol Hematol. 1985. PMID: 3013441 Review.
Cited by
-
Neutrophil progenitor populations of rhesus macaques.J Leukoc Biol. 2019 Jan;105(1):113-121. doi: 10.1002/JLB.1TA1117-431RR. Epub 2018 Nov 5. J Leukoc Biol. 2019. PMID: 30395351 Free PMC article.
-
N-formyl-methionyl-leucyl-phenylalanine inhibits both gamma interferon- and interleukin-10-induced expression of FcgammaRI on human monocytes.Clin Diagn Lab Immunol. 2001 Mar;8(2):402-8. doi: 10.1128/CDLI.8.2.402-408.2001. Clin Diagn Lab Immunol. 2001. PMID: 11238229 Free PMC article.
-
Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats.J Clin Med. 2019 Aug 20;8(8):1261. doi: 10.3390/jcm8081261. J Clin Med. 2019. PMID: 31434267 Free PMC article. Review.
-
PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells.Cell Death Dis. 2021 Nov 1;12(11):1038. doi: 10.1038/s41419-021-04318-y. Cell Death Dis. 2021. PMID: 34725321 Free PMC article.
-
Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment.Int J Mol Sci. 2017 Jul 31;18(8):1660. doi: 10.3390/ijms18081660. Int J Mol Sci. 2017. PMID: 28758974 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical